MARIA DOLORES MORAGUES TOSANTOS-rekin lankidetzan egindako argitalpenak (45)

2024

  1. Anti-Candida Antibodies of Patients with Invasive Candidiasis Inhibit Growth, Alter Cell Wall Structure, and Kill Candida albicans In Vitro

    Mycopathologia, Vol. 189, Núm. 1, pp. 16

  2. Candida albicans cDNA library screening reveals novel potential diagnostic targets for invasive candidiasis

    Diagnostic Microbiology and Infectious Disease, Vol. 109, Núm. 3

2023

  1. Molecular Identification of Fungal Species through Multiplex-qPCR to Determine Candidal Vulvovaginitis and Antifungal Susceptibility

    Journal of Fungi, Vol. 9, Núm. 12

2021

  1. Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients

    Diagnostic Microbiology and Infectious Disease, Vol. 101, Núm. 3

2019

  1. Anti-Candida albicans germ tube antibodies reduce in vitro growth and biofilm formation of C. albicans

    Revista Iberoamericana de Micologia, Vol. 36, Núm. 1, pp. 9-16

2016

  1. Candida albicans and cancer: Can this yeast induce cancer development or progression?

    Critical Reviews in Microbiology, Vol. 42, Núm. 2, pp. 181-193

2014

  1. An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array

    International Journal of Immunopathology and Pharmacology, Vol. 27, Núm. 3, pp. 403-412

  2. Candida antigens and immune responses: Implications for a vaccine

    Expert Review of Vaccines, Vol. 13, Núm. 8, pp. 1001-1012

  3. Identification of superficial Candida albicans germ tube antigens in a rabbit model of disseminated candidiasis. A proteomic approach.

    International microbiology: official journal of the Spanish Society for Microbiology, Vol. 17, Núm. 1, pp. 21-29

2012

  1. Periodontopathogen and epstein-barr virus contamination affects transplanted bone volume in sinus augmentation

    Journal of Periodontology, Vol. 83, Núm. 2, pp. 162-173

2011

  1. Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 7, pp. 3156-3163

2010

  1. Potential of anti-candida antibodies in immunoprophylaxis

    Immunotherapy, Vol. 2, Núm. 2, pp. 171-183

2009

  1. Evaluation of CHROM-Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity

    Journal of Medical Microbiology, Vol. 58, Núm. 11, pp. 1437-1442

2007

  1. Identificación rápida de Candida dubliniensis mediante la prueba Bichro-Dubli®

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. 9, pp. 576-578

2006

  1. A fungicidal monoclonal antibody protects against murine invasive candidiasis

    Infection and Immunity, Vol. 74, Núm. 5, pp. 3042-3045

  2. Diagnostic potential of (1→3)-β-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients

    Revista Iberoamericana de Micologia, Vol. 23, Núm. 4, pp. 209-215

  3. Evaluation of Bichro-Dubli Fumouze® to distinguish Candida dubliniensis from Candida albicans

    Diagnostic Microbiology and Infectious Disease, Vol. 55, Núm. 2, pp. 165-167

  4. Evaluation of the new chromogenic medium candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species

    Journal of Clinical Microbiology, Vol. 44, Núm. 9, pp. 3340-3345

  5. In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: Comparison of CLSI M27-A2, Sensitive YeastOne, disk diffusion, and Etest methods

    Microbial Drug Resistance, Vol. 12, Núm. 4, pp. 246-251

  6. Isolation of Issatchenkia occidentalis from the esophagus of a leukemic patient

    Revista Iberoamericana de Micologia, Vol. 23, Núm. 4, pp. 235-237